← Leaderboards
Elizabeth J Shpall
University Of Colorado Denver
$12,617,686
Attributed
$14,603,542
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,684,489 · 10
FDA$400,000 · 1
By mechanism
P01$33,035,434 · 6
P50$6,036,934 · 1
R01$5,451,646 · 2
R21$437,768 · 1
P30$122,707 · 1
Top collaborators
- Catherine Mary Bollard11 shared
- Katy Rezvani5 shared
- Paul Simmons4 shared
- Marina Y Konopleva3 shared
- Laurence J.N. Cooper2 shared
- Dmitri Lapotko2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Ross M Kedl$19,713,912
- James V Degregori$21,700,379
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTransplantationDoseUmbilical Cord BloodResearch PersonnelUmbilical Cord Blood TransplantationEngraftmentClinical TrialsBone MarrowStem CellsFundingHematopoietic Stem CellsHomingT-LymphocyteProceduresCell TherapyProgramsHematopoieticGrantImmuneBlood CellsClinical ResearchReconstitutionResearch Project Grants
Grant awards (69)
13 Stem Cell Transplantation and Cellular Therapy$24,690
P30 · FY2025 · CA · contact PI
13 Stem Cell Transplantation and Cellular Therapy$23,220
P30 · FY2024 · CA · contact PI
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia$918,606
P50 · FY2023 · CA · contact PI
13 Stem Cell Transplantation and Cellular Therapy$18,707
P30 · FY2023 · CA · contact PI
Novel Cord Blood-Derived Cellular Therapies$2,549,929
P01 · FY2022 · CA · contact PI
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia$1,689,836
P50 · FY2022 · CA
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD$532,406
P01 · FY2022 · CA · contact PI
Administrative Core$188,141
P01 · FY2022 · CA · contact PI
13 Stem Cell Transplantation and Cellular Therapy$18,707
P30 · FY2022 · CA · contact PI
Novel Cord Blood-Derived Cellular Therapies$2,569,848
P01 · FY2021 · CA · contact PI
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia$1,689,836
P50 · FY2021 · CA
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD$532,046
P01 · FY2021 · CA · contact PI
Administrative Core$190,439
P01 · FY2021 · CA · contact PI
13 Stem Cell Transplantation and Cellular Therapy$18,707
P30 · FY2021 · CA · contact PI
Novel Cord Blood-Derived Cellular Therapies$2,576,646
P01 · FY2020 · CA · contact PI
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia$1,738,656
P50 · FY2020 · CA
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD$531,958
P01 · FY2020 · CA · contact PI
Hematopoietic Progenitor Cells- Cord Blood$380,000
R01 · FY2020 · CA · contact PI
Administrative Core$192,767
P01 · FY2020 · CA · contact PI
13 Stem Cell Transplantation and Cellular Therapy$18,676
P30 · FY2020 · CA · contact PI
Novel Cord Blood-Derived Cellular Therapies$2,508,224
P01 · FY2019 · CA · contact PI
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD$515,866
P01 · FY2019 · CA · contact PI
Hematopoietic Progenitor Cells- Cord Blood$368,600
R01 · FY2019 · CA · contact PI
Administrative Core$189,158
P01 · FY2019 · CA · contact PI
Novel Cord Blood-Derived Cellular Therapies$1,966,908
P01 · FY2018 · CA · contact PI
Cord Blood Graft Engineering to Improve Engraftment and Reduce GVHD$540,224
P01 · FY2018 · CA · contact PI
Hematopoietic Progenitor Cells- Cord Blood$380,000
R01 · FY2018 · CA · contact PI
Administrative Core$193,887
P01 · FY2018 · CA · contact PI
Hematopoietic Progenitor Cells- Cord Blood$380,000
R01 · FY2017 · CA · contact PI
IMPROVING CORD BLOOD TRANSPLANTATION$1,247,007
P01 · FY2016 · CA · contact PI
Administrative, Regulatory and Cord Blood Bank$470,659
P01 · FY2016 · CA · contact PI
Hematopoietic Progenitor Cells- Cord Blood$380,000
R01 · FY2016 · CA · contact PI
Cord Blood Expansion and Homing to Improve Engraftment$248,200
P01 · FY2016 · CA · contact PI
IMPROVING CORD BLOOD TRANSPLANTATION$2,630,723
P01 · FY2015 · CA · contact PI
Cord Blood Expansion and Homing to Improve Engraftment$570,419
P01 · FY2015 · CA · contact PI
All-in-one purification and engineering of therapeutic cell systems$231,384
R21 · FY2015 · EB
Administrative, Regulatory and Cord Blood Bank$118,597
P01 · FY2015 · CA · contact PI
IMPROVING CORD BLOOD TRANSPLANTATION$1,030,855
P01 · FY2014 · CA · contact PI
Good Manufacturing Practice (GMP) and Immune Assessment Core$381,786
P01 · FY2014 · CA · contact PI
Hematopoietic Progenitor Cells - Cord Blood$300,665
R01 · FY2014 · CA · contact PI
Cord Blood Expansion and Homing to Improve Engraftment$221,358
P01 · FY2014 · CA · contact PI
All-in-one purification and engineering of therapeutic cell systems$206,384
R21 · FY2014 · EB
Phase 1 Study of Umbilical Cord Blood-Derived T Cells in Malignant B Cells$200,000
R01 · FY2014 · FD
Administrative, Regulatory and Cord Blood Bank$46,022
P01 · FY2014 · CA · contact PI
IMPROVING CORD BLOOD TRANSPLANTATION$2,369,877
P01 · FY2013 · CA · contact PI
Cord Blood Expansion and Homing to Improve Engraftment$514,206
P01 · FY2013 · CA · contact PI
Good Manufacturing Practice (GMP) and Immune Assessment Core$484,556
P01 · FY2013 · CA · contact PI
Hematopoietic Progenitor Cells - Cord Blood$291,366
R01 · FY2013 · CA · contact PI
Phase 1 Study of Umbilical Cord Blood-Derived T Cells in Malignant B Cells$200,000
R01 · FY2013 · FD
Administrative, Regulatory and Cord Blood Bank$103,466
P01 · FY2013 · CA · contact PI
IMPROVING CORD BLOOD TRANSPLANTATION$2,492,597
P01 · FY2012 · CA · contact PI
Cord Blood Expansion and Homing to Improve Engraftment$534,406
P01 · FY2012 · CA · contact PI
Good Manufacturing Practice (GMP) and Immune Assessment Core$394,280
P01 · FY2012 · CA · contact PI
Hematopoietic Progenitor Cells - Cord Blood$309,964
R01 · FY2012 · CA · contact PI
Administrative, Regulatory and Cord Blood Bank$111,103
P01 · FY2012 · CA · contact PI
IMPROVING CORD BLOOD TRANSPLANTATION$2,501,399
P01 · FY2011 · CA · contact PI
Good Manufacturing Practice (GMP) and Immune Assessment Core$386,666
P01 · FY2011 · CA · contact PI
Hematopoietic Progenitor Cells - Cord Blood$309,964
R01 · FY2011 · CA · contact PI
Good Manufacturing Practice (GMP) and Immune Assessment Core$398,805
P01 · FY2010 · CA · contact PI
Hematopoietic Progenitor Cells - Cord Blood$334,050
R01 · FY2010 · CA · contact PI
Hematopoietic Progenitor Cells$214,763
R01 · FY2007 · CA · contact PI
Hematopoietic Progenitor Cells$221,177
R01 · FY2006 · CA · contact PI
Hematopoietic Progenitor Cells$226,500
R01 · FY2005 · CA
Hematopoietic Progenitor Cells$226,500
R01 · FY2004 · CA
Hematopoietic Progenitor Cells$226,500
R01 · FY2003 · CA
HEMATOPOIETIC PROGENITOR CELLS$140,273
R01 · FY2002 · CA
HEMATOPOIETIC PROGENITOR CELLS$28,525
R01 · FY2002 · CA
HEMATOPOIETIC PROGENITOR CELLS$166,910
R01 · FY2001 · CA
HEMATOPOIETIC PROGENITOR CELLS$165,889
R01 · FY2000 · CA